Clinical Trial Update: The Role of Umbilical Cord Serum Therapy on Improvement of Corneal Epithelial Defect Following Diabetic Vitrectomy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating umbilical cord serum therapy to improve corneal epithelial defects following diabetic vitrectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Epithelial Defect

Drugs mentioned

• Umbilical cord serum therapy (umbilical cord serum therapy)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Corneal Epithelial Defect | Phase 1 | Status: UNKNOWN